Sai Life Sciences Ltd

It’s a new dawn. We are a publicly listed company. On December 18, 2024, our leadership team had the honour of ringing the bell at the #NSE, symbolizing the beginning of an exciting new chapter. From humble beginnings with fewer than 100 investors, we are now privileged to have the trust of over 5 lakh investors. This milestone is a culmination of 25 years of relentless scientific pursuit, resilience in the face of many challenges, and an unwavering resolve to deliver value for all our stakeholders. As we step onto the public stage, we do so with a deep sense of responsibility. We are committed to upholding the trust placed in us by our shareholders, partners, and the broader community. Our focus will remain on driving innovation, operating with integrity, and contributing to bringing new medicines to life, fast. This is only the beginning, and we will continue to 'Make it better together.' #pharma #cro #cdmo #nse #listing #sailife

Career opportunity at Sai Life Sciences. Please scan the QR code for details. #sailifesciences #pharmajobs #peptides #pharma #cro #cdmo

Dr. Sumit Chaudhary, Sonela Cavicke and Carol Chouest will be at the 4th Annual ADC Target Selection Summit in San Diego on December 10. To learn more about Sai Life Sciences, connect with our team at the event. #sailifesciences #drugdiscovery #drugdevelopment #pharma #cro #cdmo

Career opportunity at Sai Life Sciences. Please scan the QR code for details. #sailifesciences #drugdiscovery #drugdevelopment #pharmajobs #cro #cdmo #dmpk #toxicology

Dr. Sumit Chaudhary will be attending the 66th ASH Annual Meeting and Exposition in San Diego, California, on December 7-10, 2024. The event will bring together a global community of Haematologists to share diverse perspectives and work toward the common goal of advancing the fight against blood diseases. Haematological diseases encompass a wide range of disorders affecting blood cells, including anaemia, neutropenia, clotting disorders and haematological cancers. At Sai, our scientific team has experience in setting up various animal models related to haematological disorders like Leukaemia (AML & CML), Anaemia, Neutropenia & Coagulation (DIC), among others, to study mechanisms and testing potential therapeutic strategies using diverse therapeutic modalities of small molecules and degraders. To learn more about our capabilities, reach out to Sumit at the event. #sailifesciences #haematology #drugdiscovery #drugdevelopment #pharma #cro #cdmo

Victoria Steadman will be attending the Society for Medicines Research (SMR) Meeting on ‘Recent trends in medicinal chemistry and enabling technologies’ in London on December 5. The program will cover a combination of medicinal chemistry, chemistry-based drug discovery technologies, and chemical biology. Our team of synthetic and medicinal chemists consistently delivers high-quality, value-added chemistry services tailored to meet the diverse synthetic and drug discovery needs of innovator biotech and large pharmaceutical companies worldwide. With expertise spanning a broad range of chemotypes, we provide innovative solutions at every stage of the drug development process. To learn more about how Sai Life Sciences can support your innovation journey, connect with Victoria at SMR Meeting. #sailifesciences #drugdiscovery #drugdevelopment #medicinalchemistry #chemistry #pharma #cro #cdmo

Sai Life Sciences has partnered with Udyogwardhini Shikshan Sanstha (USS), a non-profit organization, to support underserved communities by offering skill development programs in high-demand sectors. These programs aim to provide job opportunities in areas such as solar panel installation, electric vehicle assembly & maintenance, electrical work, and plumbing. The first batch of electrician training has already begun in Kolthur Village, marking the launch of this collaboration. By equipping individuals from marginalized communities with practical skills, the initiative seeks to enhance employability and promote sustainable livelihoods. #sailifesciences #livelihood #csr #pharma #lifesciences #cro #cdmo #EV #renewableenergy

Veena Madappa will be attending BioFIT Event in Lille, France, on December 3 and 4, 2024. BioFIT is Europe’s premier partnering event for technology transfer, academia-industry collaborations, early-stage innovation deals, and investments in the life sciences sector. Sai Life Sciences is India’s fastest-growing Contract Research, Development, and Manufacturing Organization (CRDMO) (In terms of revenue CAGR and EBITDA CAGR over FY22-24). With 25 years of experience, the company has collaborated with global pharmaceutical and biotech innovators to enhance the drug discovery, development, and manufacturing value chain for small molecule new chemical entities (NCEs). Sai Life Sciences’ Discovery services, designed to accelerate the journey from ‘Concept to Clinic’ with speed and high-quality data, integrate Computational Chemistry, Medicinal Chemistry, Biology, DMPK, and Toxicology—all under one roof—to fast-track the DMTA (Design, Make, Test, and Analyze) cycle. Over the past five years, we have supported more than 140 small-molecule discovery programs. To learn more about how Sai Life Sciences can support your innovation journey, connect with Veena at BioFIT. #sailifesciences #cro #cdmo #drugdiscovery #drugdevelopment #pharma #lifesciences

Our team comprising Stephen H., Sreenivasulu Bandaru, S Sangaraju, Nathalie Huther, and Emma Hunt, is at BOS Manchester 2024. Nathalie will participate in a panel on 'Selecting the Optimal Outsourcing Model for Your Organisation' on November 27. To learn more about Sai Life Sciences, meet our team at Stand 42 at BOS Manchester 2024. #sailifesciences #pharma #cro #cdmo #bio2business #drugdiscovery #drugdevelopment

Our SaiGO Capability Program focuses on continuous improvement through Green Belt and Yellow Belt training sessions. We equipped our Saimers—both emerging talents and seasoned leaders—with the Lean Six Sigma skills, empowering them to drive meaningful change. In a world where the basics can be easily forgotten, we remain committed to reinforcing the importance of operational excellence. This commitment is not just a goal; it’s a culture that permeates our organization. Our two-level program provided managers with the ongoing support they needed to inspire their teams and lead with confidence. At Sai, we believe that fostering a culture of learning and improvement is key to our success. Together, we are laying the groundwork for a future defined by excellence. #sailifesciences #leansixsigma #greenbelt #yellowbelt #operationalexcellence #pharma #cro #cdmo